Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Avalanche shares continute to fall off a cliff as company ditches eye drug trial
Avalanche shares continute to fall off a cliff as company ditches eye drug trial
Avalanche shares continute to fall off a cliff as company ditches eye drug trial
Submitted by
admin
on August 14, 2015 - 10:10am
Source:
BioPharma Dive
News Tags:
Avalanche Biotechnologies
AVA-101
wet age-related macular degeneration
Headline:
Avalanche shares continute to fall off a cliff as company ditches eye drug trial
Do Not Allow Advertisers to Use My Personal information
